Drugs / Ad.hIFN-β
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00107861 | May 2005 → Sep 2006 | colorectal carcinoma, metastasis from malignant tumor of colon | Biogen | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad.hIFN-β | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00107861 ↗ |
| Known as | BG00001 | “Ad.hIFN-β (BG00001, IDEC-201)” NCT00107861 ↗ |
| Known as | IDEC-201 | “Ad.hIFN-β (BG00001, IDEC-201)” NCT00107861 ↗ |
| Route | Intravenous | “an intravenous injection of Ad.hIFN-β” NCT00107861 ↗ |